Nobixal (Tianeptine Sodium)

Tianeptine sodium enhances the reuptake of serotonin, helping to normalize serotonergic activity, and simultaneously modulates glutamatergic transmission by influencing NMDA‑receptor pathways. This combined effect supports neuroplasticity and stress‑response regulation, which contributes to its antidepressant properties.

The dosage of Nobixal is determined by the prescribing clinician based on the individual patient's condition, response, and tolerability. Physicians follow local prescribing guidelines and adjust the regimen as needed; patients should follow the prescribed instructions without self‑adjusting the dose.

Safety data for tianeptine sodium during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers typically advise women to discuss alternatives and weigh risks before initiating therapy.

To request Nobixal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.

Unlike typical selective serotonin reuptake inhibitors (SSRIs), Nobixal enhances serotonin reuptake and also modulates glutamate pathways. This distinct mechanism may offer benefits for patients who do not respond to SSRIs, but comparative efficacy and safety should be evaluated by a clinician on an individual basis.

Nobixal should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and potency throughout its shelf life.

Nobixal is taken orally, usually with or without food, as directed by the prescribing physician. The tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events include severe allergic reactions, hepatic injury, emergence of suicidal thoughts or behaviors, and serotonin syndrome—especially when combined with other serotonergic agents. Patients should seek immediate medical attention if they experience any of these symptoms.

Nobixal is contraindicated in individuals currently taking monoamine oxidase inhibitors (MAOIs) or those with known hypersensitivity to tianeptine sodium. Caution is also advised for patients with severe liver disease, uncontrolled hypertension, or a history of suicidal ideation.